Stability of Botulinum Toxin in Clinical Use

  • Henry T. Hoffman
  • Michael G. Gartlan


The Food Research Institute currently produces all the Botulinum neurotoxin (Botox) used in the United States which is marketed as Oculinum (Allergan, Inc., Irvine, CA).1 Oculinum is packaged in freeze dried form in vials of 100 mouse units (MU) that require reconstitution with preservative free normal saline for clinical use. Although Ahe FDA recommends discarding toxin that is not used within 4 hours of reconstituting,2 there is little data describing Oculinum activity past this point.3 Information is also lacking regarding the effect of refreezing Botox that has been reconstituted for use at a later time.


Botulinum Toxin Freezer Storage Cervical Dystonia Botulinum Neurotoxin Clostridium Botulinum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E.J. Schantz and E.A. Johnson, Dose standardization of botulinum toxin, Lancet. 335: 421 (1990).PubMedCrossRefGoogle Scholar
  2. 2.
    Oculinum (Botulinum Toxin Type A) package insert, Irvine, CA: Allergan; Inc., (December, 1989 ).Google Scholar
  3. 3.
    A.B. Scott, Botulinum toxin injection of eye muscles to correct strabismus, Trans Am Ophthalmol Soc. 129: 735–751 (1981).Google Scholar
  4. 4.
    NIH Consensus Development Conference on Clinical Use of Botulinum Toxin. National Institute of Health, Bethesda Maryland (November 12–14, 1990 ).Google Scholar
  5. 5.
    H.T. Hoffman, and M.G. Gartlan, Stability of botulinum toxin in clinical use, Presentation at “Botulinum Tetanus Neurotoxins; Neurotransmission and Biomedical Aspects” International Conference. Madison, Wisconsin. (May 12, 1992 ).Google Scholar
  6. 6.
    M.G. Gartlan and H.T. Hoffman, Botulinum neurotoxin A: degradation in potency with storage, Submitted to Otolaryngol Head Neck Surg. (June, 1992 ).Google Scholar
  7. 7.
    C.L. Ludlow, Personal Communication. (May 12, 1992 ).Google Scholar
  8. 8.
    EJ. Schantz and D.A. Kautter, Standardized assay for clostridium botulinum toxins,JAssoc Off Anal Chem. 61: 1, (1978).Google Scholar
  9. 9.
    G.K. McCvoy and K. Litrak, eds, American hospital formulary service drug information. Bethesda MD: American Society of Hospital Pharmacists, Inc., 1951–2 (1991).Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Henry T. Hoffman
    • 2
    • 1
  • Michael G. Gartlan
    • 1
  1. 1.Department of Otolaryngology--Head and Neck SurgeryUniversity of Iowa Hospitals and ClinicsIowa CityUSA
  2. 2.The National Center for Voice and Speech, Department of Speech Pathology and AudiologyThe University of IowaIowa CityUSA

Personalised recommendations